World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
36095
World Ranking
750
National Ranking
426

Medicine

D-Index
99
Citations
36124
World Ranking
8594
National Ranking
4429

Eli Gilboa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eli Gilboa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 241 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eli Gilboa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eli Gilboa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Eli Gilboa is affiliated with the University of Miami in the United States and has contributed to research primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, including Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, and Biotechnology.

The scientist's research focuses strongly on immunotherapy and immune responses, notably in cancer treatment contexts. Main topics of their work include:

  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Research and Treatments
  • RNA Interference and Gene Delivery
  • Virus-based gene therapy research
  • Pomegranate: compositions and health benefits

Eli Gilboa has published in several journals with repeated contributions to venues such as:

  • Cancer Immunology Research
  • Journal of Clinical Oncology
  • Cancer Research Communications
  • Cornea
  • Molecular Therapy - Nucleic Acids

Some of their recent papers include:

  • "Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer" (2023), Cancer Research Communications
  • "Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors" (2020), Cancer Immunology Research
  • "Aptamer-mediated transcriptional gene silencing of Foxp3 inhibits regulatory T cells and potentiates antitumor response" (2021), Molecular Therapy - Nucleic Acids
  • "A Novel Artificial Endothelial Replacement Membrane for the Treatment of Chronic Corneal Edema" (2024), Cornea
  • "Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma." (2021), Journal of Clinical Oncology

Eli Gilboa frequently collaborates with other researchers, with some common co-authors being:

  • Brett Schrand (3 publications)
  • Agata Levay (3 publications)
  • Ailem Rabasa (3 publications)
  • Greta Garrido (2 publications)
  • Anthony Ferrantella (2 publications)

Best Publications

  • Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

    David Boczkowski;Smita K. Nair;David Snyder;Eli Gilboa

  • Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

    James O McNamara;Eran R Andrechek;Yong Wang;Kristi D Viles

  • Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

    Jens Dannull;Zhen Su;David Rizzieri;Benjamin K. Yang

  • Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

    Bernd Gansbacher;Karen Zier;Brian Daniels;Kathy Cronin

  • DC-based cancer vaccines

    Eli Gilboa

  • Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors

    Gordon Keller;Christopher Paige;Eli Gilboa;Erwin F. Wagner

  • Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

    S F Yu;T von Rüden;P W Kantoff;C Garber

  • Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

    Axel Heiser;Doris Coleman;Jens Dannull;Donna Yancey

  • A detailed model of reverse transcription and tests of crucial aspects.

    Eli Gilboa;Sudha W. Mitra;Stephen Goff;David Baltimore

  • Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

    Bruce A. Sullenger;Humilidad F. Gallardo;Grace E. Ungers;Eli Gilboa

  • Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

    Zhen Su;Jens Dannull;Axel Heiser;Donna Yancey

  • Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

    David M. Ashley;Brenda Faiola;Smita Nair;Laura P. Hale

  • Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

    Bernd Gansbacher;Rajat Bannerji;Brian Daniels;Karen Zier

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • The Makings of a Tumor Rejection Antigen

    Eli Gilboa

  • Emerging clinical applications of RNA

    Bruce A. Sullenger;Eli Gilboa

  • Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA

    Stephen P. Goff;Eli Gilboa;Owen N. Witte;David Baltimore

  • Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

    S K Nair;D Boczkowski;M Morse;R I Cumming

  • Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

    Smita K. Nair;Axel Heiser;David Boczkowski;Anish Majumdar

  • Cancer immunotherapy with mRNA-transfected dendritic cells

    Eli Gilboa;Johannes Vieweg

Frequent Co-Authors

Smita Nair
Smita Nair Duke University
Bruce A. Sullenger
Bruce A. Sullenger Duke University
James O McNamara
James O McNamara Duke University
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Michael A. Morse
Michael A. Morse Duke University
Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
Wayne F. Anderson
Wayne F. Anderson Northwestern University
William R. Fair
William R. Fair Memorial Sloan Kettering Cancer Center
Benoît Van den Eynde
Benoît Van den Eynde Ludwig Cancer Research
Warren D.W. Heston
Warren D.W. Heston Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare fields, especially nursing. For those interested in advancing their nursing credentials alongside immunological knowledge, several online educational pathways are available. For instance, registered nurses aiming to specialize can explore programs to transition from FNP to acute care NP, which offers advanced clinical expertise relevant to acute immunological conditions.

Accelerated options are popular for faster entry into the field. Many students consider an accelerated nurse practitioner program to complete their studies more quickly while gaining essential skills. These programs are designed to accommodate working professionals and provide flexibility through online formats.

For individuals without prior nursing experience, online BSN programs for non nurses present an excellent entry point into the healthcare arena, paving the way to specialized immunology roles. Such programs equip students with foundational nursing knowledge necessary for effective patient care in immunology settings.

Moreover, accelerated nursing programs offer accessible routes to earn nursing credentials faster than traditional programs. These pathways enable students to quickly build a robust skill set to support careers in research, clinical practice, or healthcare management related to immunology.

Best Scientists Citing Eli Gilboa

Trending Scientists

Recently Published Articles